Oncology Grand Rounds Series: Part 2 — Hodgkin and Non-Hodgkin Lymphomas

1:56:01
 
Share
 

Manage episode 236839109 series 1464173
By Dr Neil Love. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

Video proceedings from the second in a series of 6 integrated symposia held at the 2019 ONS Annual Congress. Featuring perspectives from Dr Christopher R Flowers, Ms Amy Goodrich, Dr Patrick B Johnston and Ms Robin Klebig:

  • Introduction (00:00)
    • Program overview: Dr Love
  • Hodgkin Lymphoma (HL) (2:51)
  • Case (Ms Klebig): A woman in her early 50s with HL who received up-front brentuximab vedotin with ABVD on a clinical trial and nivolumab after relapse (5:57)
  • Case (Ms Goodrich): A man in his mid-50s with relapsed HL who received brentuximab vedotin as a bridge to allogenic transplant (26:12)
  • Follicular Lymphoma (FL) (37:16)
  • Case (Ms Klebig): A man in his late 50s with multiply relapsed FL who received lenalidomide/rituximab with response and clinical improvement (38:46)
  • Case (Ms Goodrich): A man in his late 40s with relapsed FL who received copanlisib (1:07:01)
  • Mantle Cell Lymphoma (MCL) (1:09:53)
  • Case (Ms Goodrich): A man in his early 80s with relapsed MCL and multiple comorbidities who received acalabrutinib (1:19:36)
  • Case (Ms Goodrich): A man in his early 60s who received multiple lines of therapy for relapsed MCL, including venetoclax/rituximab (1:27:21)
  • Diffuse Large B-Cell Lymphoma (DLBCL) (1:34:06)
  • Case (MS Klebig): A woman in her mid-30s with relapsed triple-hit DLBCL who underwent chimeric antigen receptor T-cell therapy (1:34:12)
  • Case (Ms Klebig): A woman in her mid-30s with DLBCL who received CNS prophylaxis with high-dose methotrexate (1:37:16)

Select publications

2183 episodes